At meeting held on 02 December 2016
AstraZeneca Pharma India announced that the Board of Directors of the Company at its meeting held on 02 December 2016 has approved the following change in directorate -Accepted the resignation of D E Udwadia as Director of the Company with effect from 02 December 2016.
Accepted resignation of K S Shah as Director of the Company with effect from 02 December 2016.
Accepted resignation of Claire-Marie O'Grady as Director of the Company with effect from 02 December 2016.
Revathy Ashok and Greg Mueller have been co-opted as Additional Directors on the Board of the Directors with immediate effect.
Also Read
Rajesh Marwah, CFO of the Company has been inducted into the board as Additional and Whole Time Director.
Narayan K Sheshadri has been elected as Chairman of Board.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
